| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMIGRAN DR 100 mg | SUMATRIPTANUM | COMPR. DISP. | N02CC01 | W64948003 | GLAXOSMITHKLINE (IRELAND) LIMITED - IRLANDA | ||||||
| IMIGRAN DR 100 mg | SUMATRIPTANUM | COMPR. DISP. | N02CC01 | W64948004 | GLAXOSMITHKLINE (IRELAND) LIMITED - IRLANDA | ||||||
| IMIGRAN DR 100 mg | SUMATRIPTANUM | COMPR. DISP. | N02CC01 | W64948005 | GLAXOSMITHKLINE (IRELAND) LIMITED - IRLANDA | ||||||
| IMIGRAN DR 50 mg | SUMATRIPTANUM | COMPR. DISP. | N02CC01 | W64946001 | GLAXOSMITHKLINE (IRELAND) LIMITED - IRLANDA | ||||||
| IMIGRAN DR 50 mg | SUMATRIPTANUM | COMPR. DISP. | N02CC01 | W64946002 | GLAXOSMITHKLINE (IRELAND) LIMITED - IRLANDA | ||||||
| IMIGRAN DR 50 mg | SUMATRIPTANUM | COMPR. DISP. | N02CC01 | W64946003 | GLAXOSMITHKLINE (IRELAND) LIMITED - IRLANDA | ||||||
| IMIGRAN DR 50 mg | SUMATRIPTANUM | COMPR. DISP. | N02CC01 | W64946004 | GLAXOSMITHKLINE (IRELAND) LIMITED - IRLANDA | ||||||
| IMIGRAN DR 50 mg | SUMATRIPTANUM | COMPR. DISP. | N02CC01 | W64946005 | GLAXOSMITHKLINE (IRELAND) LIMITED - IRLANDA | ||||||
| IMIPENEM/CILASTATIN APTAPHARMA 500 mg/500 mg | IMIPENEMUM+CILASTATINUM | PULB. PT. SOL. PERF. | J01DH51 | W65488001 | APTA MEDICA INTERNACIONAL D.O.O. - SLOVENIA | ||||||
| IMIPENEM/CILASTATIN ATB 500 mg/500 mg | IMIPENEMUM+CILASTATINUM | PULB. PT. SOL. PERF. | J01DH51 | W61198001 | ANTIBIOTICE S.A. - ROMANIA | ||||||
| IMIPENEM/CILASTATIN ATB 500 mg/500 mg | IMIPENEMUM+CILASTATINUM | PULB. PT. SOL. PERF. | J01DH51 | W61198002 | ANTIBIOTICE S.A. - ROMANIA | ||||||
| IMIPENEM/CILASTATIN ATB 500 mg/500 mg | IMIPENEMUM+CILASTATINUM | PULB. PT. SOL. PERF. | J01DH51 | W61198003 | ANTIBIOTICE S.A. - ROMANIA | ||||||
| IMIPENEM/CILASTATIN STERISCIENCE 500 mg/500 mg | IMIPENEMUM+CILASTATINUM | PULB. PT. SOL. PERF. | J01DH51 | W70365001 | STERISCIENCE B.V. - TARILE DE JOS | ||||||
| IMIPENEM/CILASTATIN STERISCIENCE 500 mg/500 mg | IMIPENEMUM+CILASTATINUM | PULB. PT. SOL. PERF. | J01DH51 | W70365002 | STERISCIENCE B.V. - TARILE DE JOS | ||||||
| IMIPENEM/CILASTATINA KABI 500 mg/500 mg | IMIPENEMUM+CILASTATINUM | PULB. PT. SOL. PERF. | J01DH51 | W54532001 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| IMIPENEM/CILASTATINA KABI 500 mg/500 mg | IMIPENEMUM+CILASTATINUM | PULB. PT. SOL. PERF. | J01DH51 | W54532002 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| IMJUDO 20 mg/ml | TREMELIMUMABUM | CONC. PT. SOL. PERF. | L01FX20 | W69596001 | ASTRAZENECA AB - SUEDIA | X | |||||
| IMJUDO 20 mg/ml | TREMELIMUMABUM | CONC. PT. SOL. PERF. | L01FX20 | W69596002 | ASTRAZENECA AB - SUEDIA | X | |||||
| IMMUNATE 1000 UI FVIII/750 UI FVW | FACTOR VIII DE COAGULARE SI FACTOR VON WILLEBRAND | PULB.+SOLV. PT. SOL. INJ. | B02BD06 | W62888001 | BAXALTA INNOVATIONS GMBH - AUSTRIA | ||||||
| IMMUNATE 250 UI FVIII/190 UI FVW | FACTOR VIII DE COAGULARE SI FACTOR VON WILLEBRAND | PULB.+SOLV. PT. SOL. INJ. | B02BD06 | W62886001 | BAXALTA INNOVATIONS GMBH - AUSTRIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman